Novartis to buy breast cancer drug in deal worth up to $3 billion

AI Briefing

• – Novartis to acquire breast cancer drug in $3 billion deal.
• – Deal strengthens pipeline of targeted cancer treatments.
• – Swiss drugmaker to pay $2 billion upfront, with $1 billion tied to development milestones.